Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Automated segmentation of blood cells in Giemsa stained digitized thin blood films

(2013) Margarita Walliander et al.   Diagnostic Pathology

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population

(2013) Ling Shan et al.   Diagnostic Pathology

Targeted Deletion of MicroRNA-22 Promotes Stress-Induced Cardiac Dilation and Contractile Dysfunction

(2012) Priyatansh Gurha et al.   CIRCULATION

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma

(2012) Jingchun Jin et al.   Diagnostic Pathology

The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays

(2012) Kambiz Sotoudeh et al.   Diagnostic Pathology

Macro-Role of MicroRNA in Gastric Cancer

(2012) Alexander Link et al.   DIGESTIVE DISEASES

Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3

(2012) Bo Ling et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer

(2012) Ming-yang Song et al.   PLoS One

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic analysis of familial gastric cancer in Chinese population

(2011) Yan-Wei Ye et al.   JOURNAL OF SURGICAL ONCOLOGY

MicroRNA-22 Regulates Hypoxia Signaling in Colon Cancer Cells

(2011) Munekazu Yamakuchi et al.   PLoS One

Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling

(2011) Yue-Zheng Zhang   WORLD JOURNAL OF GASTROENTEROLOGY

Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression

(2010) Yi Ting et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

(2010) J Zhang et al.   BRITISH JOURNAL OF CANCER

An estrogen receptor α suppressor, microRNA-22, is downregulated in estrogen receptor α-positive human breast cancer cell lines and clinical samples

(2010) Jianhua Xiong et al.   FEBS Journal

An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer

(2010) Jun Li et al.   GYNECOLOGIC ONCOLOGY

MicroRNA dysregulation in gastric cancer: a new player enters the game

(2010) W K K Wu et al.   ONCOGENE

Identification of the miR-106b 25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation

(2010) L. Poliseno et al.   Science Signaling

miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide

(2010) Linhua Liu et al.   TOXICOLOGY IN VITRO

Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks

(2008) Dimitrios Iliopoulos et al.   PLoS One